These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33119615)

  • 1. G82S RAGE polymorphism influences amyloid-RAGE interactions relevant in Alzheimer's disease pathology.
    C RC; Lukose B; Rani P
    PLoS One; 2020; 15(10):e0225487. PubMed ID: 33119615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparagine 81: comparison of wild-type rage with the G82S polymorphic variant.
    Park SJ; Kleffmann T; Hessian PA
    J Biol Chem; 2011 Jun; 286(24):21384-92. PubMed ID: 21511948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased soluble RAGE in neutrophilic asthma is correlated with disease severity and RAGE G82S variants.
    Lyu Y; Zhao H; Ye Y; Liu L; Zhu S; Xia Y; Zou F; Cai S
    Mol Med Rep; 2018 Mar; 17(3):4131-4137. PubMed ID: 29257350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G82S RAGE polymorphism is associated with Alzheimer's disease.
    Chellappa RC; Rani P
    Front Biosci (Elite Ed); 2020 Mar; 12(1):150-161. PubMed ID: 32114455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts.
    Osawa M; Yamamoto Y; Munesue S; Murakami N; Sakurai S; Watanabe T; Yonekura H; Uchigata Y; Iwamoto Y; Yamamoto H
    Biochim Biophys Acta; 2007 Oct; 1770(10):1468-74. PubMed ID: 17714874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the RAGE G82S polymorphism and Alzheimer's disease.
    Li K; Dai D; Zhao B; Yao L; Yao S; Wang B; Yang Z
    J Neural Transm (Vienna); 2010 Jan; 117(1):97-104. PubMed ID: 19902324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between the RAGE G82S polymorphism, sRAGE and chronic periodontitis in Taiwanese individuals with and without diabetes.
    Wu TL; Tsai CC; Wang YY; Ho KY; Wu YM; Hung HC; Lin YC
    J Periodontal Res; 2015 Dec; 50(6):881-9. PubMed ID: 25988707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G82S polymorphism of receptor for advanced glycation end products gene and serum soluble RAGE levels in mild cognitive impairment and dementia of Alzheimer's type patients in Turkish population.
    Ataç ZS; Alaylıoğlu M; Dursun E; Gezen-Ak D; Yılmazer S; Gürvit H
    J Clin Neurosci; 2019 Jan; 59():197-201. PubMed ID: 30389362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking and Molecular Dynamics-Based Identification of Interaction between Various Beta-Amyloid Isoforms and RAGE Receptor.
    Tolstova AP; Adzhubei AA; Mitkevich VA; Petrushanko IY; Makarov AA
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid β peptide-mediated neuronal disorder.
    Cai C; Dai X; Zhu Y; Lian M; Xiao F; Dong F; Zhang Q; Huang Y; Zheng Q
    Appl Microbiol Biotechnol; 2016 Jan; 100(2):825-35. PubMed ID: 26496918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).
    Mehta R; Shaw G; Masschelin P; Felix S; Otgonsuren M; Baranova A; Goodman Z; Younossi Z
    PLoS One; 2018; 13(6):e0199294. PubMed ID: 29928018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAGE mediates Aβ accumulation in a mouse model of Alzheimer's disease via modulation of β- and γ-secretase activity.
    Fang F; Yu Q; Arancio O; Chen D; Gore SS; Yan SS; Yan SF
    Hum Mol Genet; 2018 Mar; 27(6):1002-1014. PubMed ID: 29329433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of K16A and K28A mutation on the structure and dynamics of amyloid-β
    Shuaib S; Saini RK; Goyal D; Goyal B
    J Biomol Struct Dyn; 2020 Feb; 38(3):708-721. PubMed ID: 30821624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling.
    Xue J; Manigrasso M; Scalabrin M; Rai V; Reverdatto S; Burz DS; Fabris D; Schmidt AM; Shekhtman A
    Structure; 2016 Sep; 24(9):1509-22. PubMed ID: 27524199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products.
    Mruthinti S; Sood A; Humphrey CL; Swamy-Mruthinti S; Buccafusco JJ
    Neuroscience; 2006 Oct; 142(2):463-73. PubMed ID: 16890367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
    Xu L; Chen Y; Wang X
    Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The promoter polymorphisms of receptor for advanced glycation end products were associated with the susceptibility and progression of sepsis.
    Shao Y; Shao X; He J; Cai Y; Zhao J; Chen F; Tao H; Yin Z; Tan X; He Y; Lin Y; Li K; Cui L
    Clin Genet; 2017 Apr; 91(4):564-575. PubMed ID: 27172264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.
    Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA
    CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentamidine blocks the interaction between mutant S100A5 and RAGE V domain and inhibits the RAGE signaling pathway.
    Cho CC; Chou RH; Yu C
    Biochem Biophys Res Commun; 2016 Aug; 477(2):188-94. PubMed ID: 27297108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.